Celldex (CLDX) Posts Smaller Q4 Loss

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.03), $0.22 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $1.35 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Vicor raises Q3 2026 revenue guidance on new licensing deal
• DA Davidson Reiterates Buy Rating on Vulcan Materials Company (VMC)